To assess whether FADS2 is required for PPARα‐mediated suppression of psoriatic inflammation in vivo, we knocked down Fads2 using siRNA and administered WY14643 in IMQ‐induced psoriasis‐like skin lesions (Figure8A). This evidence concerns the gene FADS2 and psoriasis.